Researcher interests: Pharmacokinetics and biopharmaceutics of existing and new drugs. Pharmacokinetic-based design of new antiepileptics and CNS drugs.
FACULTY / SCHOOL: School of Medicine - IMRIC
DEPARTMENT: School of Pharmacy- Institute for Drug Research
Selected Publications
novel treatment approaches and pediatric research networks in status epilepticus (2019)|
Epilepsy & Behavior|
Read more
a summary of data presented at the xiv conference on new antiepileptic drug and devices eilat xiv (2019)|
Epilepsy Research|
Read more
comparative efficacy of valnoctamide and sec butylpropylacetamide spd in terminating nerve agent induced seizures in pediatric rats (2019)|
Epilepsia|
Read more
stereoselective pharmacokinetic and pharmacodynamic analysis of a cns active sulphamoylphenyl carbamate derivative (2019)|
Journal of Enzyme Inhibition and Medicinal Chemistry|
Read more
teratogenicity of valproic acid and its constitutional isomer amide derivative valnoctamide in mice (2018)|
Birth defects research|
Read more
progress report on new antiepileptic drugs a summary of the fourteenth eilat conference on new antiepileptic drugs and devices eilat xiv ii drugs in more advanced clinical development (2018)|
Epilepsia|
Read more
mitochondrial liver toxicity of valproic acid and its acid derivatives is related to inhibition of α lipoamide dehydrogenase (2017)|
International Journal of Molecular Sciences|
Read more
design and comparative evaluation of the anticonvulsant profile carbonic anhydrate inhibition and teratogenicity of novel carbamate derivatives of branched aliphatic carboxylic acids with 4 aminobenzensulfonamide (2017)|
Neurochemical Research|
Read more
a randomized double blind placebo and risperidone controlled study on valnoctamide for acute mania (2017)|
Bipolar Disorders|
Read more
seizure detection and neuromodulation a summary of data presented at the xiii conference on new antiepileptic drug and devices eilat xiii (2017)|
Epilepsy Research|
Read more
